Mandate

Vinge advises Lantmännen in conjunction with acquisition from Tate&Lyle

March 28, 2019 M&A

Vinge has advised Lantmännen in connection with its acquisition of British Tate&Lyle’s Swedish oat production operations.

The acquisition is a part of Lantmännen’s continued focus on additional processing of oats to, inter alia, the food manufacturing industry.

Vinge’s team consisted of partner Christina Kokko together with, among others, associates Karl Klackenberg and David Lundahl (M&A), partner Johan Cederblad and associate Hampus Olsson (Environmental/Permits) as well as associates Hedvig Ekdahl (Commerical Agreements), Lisa Ullman (Employment), Karolina Cohrs (Real Property) and Klara Secher (IP).
 

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026